Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIMP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RBM26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHL18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100132207 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
PPP4R1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
F11-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF382 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927533 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAX8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930286 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC643711 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM92 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on